Brian C. Unger
About Brian C. Unger
Brian C. Unger serves as the Competitive Intelligence and Pipeline Planning Lead at Alpine Immune Sciences, Inc. He has extensive experience in oncology marketing and product planning, having held key positions at several leading pharmaceutical companies.
Work at Alpine Immune Sciences
Brian C. Unger currently holds the position of Competitive Intelligence and Pipeline Planning Lead at Alpine Immune Sciences, Inc. since 2023. In this role, he focuses on leveraging market insights and analytics to enhance the company's oncology product offerings. His responsibilities include developing strategies that align with the company's goals and optimizing pipeline planning to support future product launches.
Previous Experience in Oncology
Brian has extensive experience in the oncology sector, having worked in various leadership roles at notable companies. He served as the Head of New Product/Portfolio Planning for Global Immuno-oncology and Oncology at Merck Group from 2014 to 2017. He also held the position of Head of Marketing for US Hematology-Oncology at AMAG Pharmaceuticals from 2019 to 2020. His tenure at Sanofi as Senior Director for Global Oncology from 2010 to 2014 further solidified his expertise in developing and marketing oncology assets.
Educational Background
Brian C. Unger has a solid educational foundation in chemistry and business. He earned a Bachelor of Science (BS) in Chemistry and a Master of Science (MS) in Analytical Biochemistry from Illinois State University. Additionally, he obtained a Master of Business Administration (MBA) with a focus on Marketing from the University of Michigan - Stephen M. Ross School of Business. This combination of scientific and business education supports his work in the competitive landscape of oncology.
Career Development and Skills
Throughout his career, Brian has developed a strong background in commercial launch-readiness strategies for novel oncology molecules. His experience spans several key roles at companies such as Genentech and Karyopharm Therapeutics Inc., where he was involved in commercial and portfolio strategy. His ability to utilize market insights and analytics has led to significant increases in sales for marketed oncology products, demonstrating his effectiveness in the field.
Notable Positions Held
Brian has held various significant positions in the pharmaceutical industry. He worked as a Launch Lead for the MET-inhibitor Program at Merck Group from 2016 to 2018 and as a Senior Product Manager at Chiron Corporation in 2002. His diverse roles across different companies have equipped him with a comprehensive understanding of the oncology market and product development processes.